Shares of Stericycle Inc (NASDAQ:SRCL) have earned an average rating of “Hold” from the fourteen ratings firms that are covering the stock, MarketBeat reports. Two analysts have rated the stock with a sell rating, six have issued a hold rating and five have assigned a buy rating to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $72.44.
A number of brokerages have issued reports on SRCL. BidaskClub upgraded Stericycle from a “sell” rating to a “hold” rating in a report on Wednesday, January 31st. Zacks Investment Research upgraded Stericycle from a “sell” rating to a “hold” rating in a report on Wednesday, January 10th. Royal Bank of Canada raised their target price on Stericycle to $75.00 and gave the stock an “underperform” rating in a report on Friday, January 19th. Barrington Research reduced their target price on Stericycle from $87.00 to $75.00 and set an “outperform” rating on the stock in a report on Friday, November 10th. Finally, BMO Capital Markets reaffirmed a “hold” rating and set a $72.00 price target on shares of Stericycle in a research report on Wednesday, January 24th.
In other news, Director Mark C. Miller sold 19,753 shares of the firm’s stock in a transaction dated Monday, November 27th. The stock was sold at an average price of $63.33, for a total transaction of $1,250,957.49. Following the sale, the director now owns 205,854 shares of the company’s stock, valued at $13,036,733.82. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In the last ninety days, insiders have sold 59,259 shares of company stock worth $3,847,687. 3.50% of the stock is currently owned by insiders.
Stericycle (NASDAQ SRCL) opened at $70.15 on Friday. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.93. Stericycle has a 1-year low of $61.25 and a 1-year high of $88.00. The stock has a market capitalization of $6,023.06, a PE ratio of -123.07, a price-to-earnings-growth ratio of 1.71 and a beta of 0.26.
Stericycle (NASDAQ:SRCL) last issued its earnings results on Wednesday, November 8th. The business services provider reported $1.10 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.14 by ($0.04). Stericycle had a positive return on equity of 13.93% and a negative net margin of 0.79%. The company had revenue of $883.00 million for the quarter, compared to the consensus estimate of $896.81 million. During the same quarter last year, the business posted $1.24 EPS. Stericycle’s quarterly revenue was down .8% on a year-over-year basis. sell-side analysts expect that Stericycle will post 4.49 EPS for the current year.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.